Global ADCs market to grow at a CAGR of 41.58% during the period 2016-2020

About Antibody Drug Conjugates

ADCs, empowered monoclonal antibodies (mAbs), use chemical linkers with labile bonds to attach biologically active substances. ADCs target mAbs with the cancer killing ability of cytotoxic drugs, allowing sensitive discernment between healthy and diseased tissue.

Antibodies are the proteins produced by B-cells (from bone marrow) in the immune system. These proteins attach to antigens, which act as markers, and are then destroyed by phagocytes. B-cells produce different antibodies that attach to different sites of an antigen. mAbs, complex proteins with high molecular weight, are monospecific as they are the clones of a single parent cell. They are of three types, chimeric, humanized, and fully human, and are often used for therapeutic and diagnostic purposes.

To Browse a Full Report with TOC: http://www.researchmoz.us/global-antibody-conjugates-drugs-market-2016-2020-report.html

Technavios analysts forecast the global ADCs market to grow at a CAGR of 41.58% during the period 2016-2020.

Covered in this report 

The report covers the present scenario and the growth prospects of the global ADCs market for the period 2015-2020. To calculate the market size, the report considers revenue generated from the sales of ADCs used to treat cancer.

The market is divided into the following segments based on geography: 

Americas

APAC

EMEA

Technavio's report, Global Antibody Drug Conjugates Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors 

F. Hoffmann-La Roche AG

Seattle Genetics Inc.

Takeda Pharmaceutical Company

Other prominent vendors 

AbbVie

AbGenomics

ADC Therapeutics

Agensys

ALMAC Group

Ambrx

Astellas Pharma

AstraZeneca

Bayer HealthCare

CARBOGEN AMCIS

Celldex Therapeutics

Daiichi Sankyo

Endo Pharmaceuticals

Esperance Pharmaceuticals

Read All Medical Equipments Market Research Reports @ http://www.researchmoz.us/medical-equipments-market-reports-109.html

Formation Biologics

Genmab

GlaxoSmithKline

Immunogen

Kairos Therapeutics

MedImmune

Mersana Therapeutics

Novartis

Oxford Biotherapeutics

Pfizer

Stemcentrx

Synthon Biopharmaceuticals

Zymeworks

Market driver 

Robust late-stage pipeline

For a full, detailed list, view our report

Market challenge 

High developmental costs

For a full, detailed list, view our report

Market trend 

Strategic alliances

For a full, detailed list, view our report

To Download Sample Report With TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=700592

Key questions answered in this report 

What will the market size be in 2020 and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by the key vendors?

What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.

For More Information Kindly Contact:

ResearchMoz

Mr. Nachiket Ghumare, +1–518–621–2074

USA-Canada Toll Free: 866–997–4948

Email: sales@researchmoz.us

Follow us on LinkedIn at: http://bit.ly/1TBmnVG